If so, this is the right place
3) REDEFINE-1 (NEJM 2024, n=3417, 68 weeks) CagriSema (cagrilintide 2.4 + semaglutide 2.4) 22.7% weight (ozempic 2.4 16.1%, cagrilintide 2.4 mono 11.8%, placebo 2.3%)
Figure 2: Changes in body weight from baseline to the end of treatment at week 26 associated with the treatment policy estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
This means it helps shield your brain from the negative effects of stress and other potential damage
Follicle stimulation, density, energy
Examples from related peptide use indicate cautious low-dose trials under supervision, not routine high-dose supplementation